Overcoming Common Challenges
There are many challenges pharma and biotech companies face when mapping a patient journey:
- Siloed journeys for each stakeholder
- Insights that are not actionable
- Insights that are factual, not multidimensional
- Nuanced dynamics across stakeholders that are not well captured
- Difficulty of uncovering experience and nuances in journey in rare disease
- Journeys focused on average and difficult to quantify
- Journeys made at a single point in time and “left on the shell”
How Do We Do It?
With 50+ qualitative and quantitative patient journeys completed and robust experience delivering patient journey insights to stakeholders across the industry, our tailored approach uncovers rich insights and actionable opportunities for all stakeholders. At EVERSANA, we use a qualitative approach to capture the nuanced experience of even small patient groups. We get to know the facts and feelings that influence both patient and provider beliefs and behaviors.
Take a sneak peek into the elements impacting the patient journey by exploring our featured content.